Mather Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.22M | Buy |
33,531
+3,153
| +10% | +$585K | 0.07% | 105 |
|
|
2025
Q1 | $6.36M | Buy |
30,378
+644
| +2% | +$135K | 0.07% | 102 |
|
|
2024
Q4 | $5.28M | Buy |
29,734
+950
| +3% | +$169K | 0.07% | 108 |
|
|
2024
Q3 | $5.68M | Sell |
28,784
-32,701
| -53% | -$6.46M | 0.07% | 107 |
|
|
2024
Q2 | $11.2M | Buy |
61,485
+34,287
| +126% | +$6.24M | 0.14% | 77 |
|
|
2024
Q1 | $4.21M | Sell |
27,198
-12,300
| -31% | -$1.91M | 0.07% | 104 |
|
|
2023
Q4 | $6.12M | Buy |
39,498
+1,787
| +5% | +$277K | 0.1% | 84 |
|
|
2023
Q3 | $5.62M | Buy |
37,711
+2,036
| +6% | +$303K | 0.1% | 81 |
|
|
2023
Q2 | $4.81M | Buy |
35,675
+857
| +2% | +$115K | 0.08% | 99 |
|
|
2023
Q1 | $5.55M | Buy |
34,818
+8,355
| +32% | +$1.33M | 0.1% | 82 |
|
|
2022
Q4 | $4.28M | Sell |
26,463
-298
| -1% | -$48.2K | 0.08% | 90 |
|
|
2022
Q3 | $3.59M | Buy |
26,761
+3,356
| +14% | +$450K | 0.08% | 91 |
|
|
2022
Q2 | $3.59M | Buy |
23,405
+410
| +2% | +$62.8K | 0.08% | 88 |
|
|
2022
Q1 | $3.73M | Buy |
+22,995
| New | +$3.73M | 0.07% | 83 |
|
|
2020
Q4 | – | Sell |
-18,206
| Closed | -$1.6M | – | 250 |
|
|
2020
Q3 | $1.6M | Buy |
18,206
+641
| +4% | +$56.2K | 0.06% | 68 |
|
|
2020
Q2 | $1.73M | Buy |
+17,565
| New | +$1.73M | 0.08% | 64 |
|